-
241
Elderly Patients Are at Greater Risk of Cytopenia During Antiviral Therapy for Hepatitis C
Published 2006-01-01“…The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. …”
Get full text
Article -
242
Characterization of the First Marine Pestivirus, Phocoena Pestivirus (PhoPeV)
Published 2025-01-01“…Pestiviruses generally counteract the cellular innate immune response by degradation of interferon regulatory factor 3 (IRF3) mediated by the viral N-terminal protease (N<sup>pro</sup>). …”
Get full text
Article -
243
Cytokines and Water Distribution in Anorexia Nervosa
Published 2021-01-01“…Following blood collection, 27 cytokines and chemokines were quantified using multiplex ELISA-based technology: Eotaxin, Eotaxin-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon- (IFN-) γ, interleukin- (IL-) 1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12/IL-23p40, IL-12p70, IL-13, IL-15, IL-16, IL-17A, interferon γ-induced protein- (IP-) 10, macrophage inflammatory protein- (MIP-) 1α, MIP-1β, monocyte chemoattractant protein- (MCP-) 1, MCP-4, thymus and activation-regulated chemokine (TARC), TNF-α, and TNF-β. …”
Get full text
Article -
244
Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients
Published 2006-01-01“…The efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. The aim of the present study was to identify the clinical, socioeconomic and health-system predictors of antiviral treatment for HCV.…”
Get full text
Article -
245
Hyperferritinemia at the patient with chronic hepatitis C
Published 2009-02-01“…., 38 years, despite of rapid virologic response at combined antiviral therapy by pegilated interferon α-2а and ribavirin, had persistently high activity of transaminases and initially high level of serum ferritin increase twice.Conclusion. …”
Get full text
Article -
246
A Rare Form of Chronic Granulomatous Disease (Type Iva) Presenting as Inflammatory Bowel Disease
Published 1996-01-01“…His gastrointestinal symptoms markedly improved during therapy with gamma-interferon. Chronic granulomatous disease can present initially with a clinical picture suggestive of chronic intestinal inflammation. …”
Get full text
Article -
247
CANDLE syndrome – a narrative review
Published 2024-09-01“…The syndrome is associated with gene mutations encoding proteasome or immunoproteasome subunits, particularly PSMB8, contributing to disrupted proteostasis and aberrant type 1 interferon production. The diagnostic criteria remain undefined, necessitating a multidisciplinary approach for accurate diagnosis and management. …”
Get full text
Article -
248
Comparative Performance of Ante-Mortem Diagnostic Assays for the Identification of <i>Mycobacterium bovis</i>-Infected Domestic Dogs (<i>Canis lupus familiaris</i>)
Published 2025-01-01“…Circulating serum cytokine concentrations of interferon gamma and TNF-α were not statistically different between the high- and low-risk groups of dogs. …”
Get full text
Article -
249
DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge
Published 2025-02-01“…DDO268 safely induces local type I interferon production and stimulates dendritic cell activation providing enhanced protection against IAV challenge. …”
Get full text
Article -
250
Viral Response to Specifically Targeted Antiviral Therapy for Hepatitis C and the Implications for Treatment Success
Published 2010-01-01“…Strategies including induction dosing with interferon and ribavirin, use of combination high-potency STAT-C molecules and an intensive emphasis on adherence to HCV antiviral therapy will be critical to the success of this promising advance in HCV therapy.…”
Get full text
Article -
251
Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity
Published 2003-01-01“…Serum levels of interleukin (IL)-6, IL-7, IL-8, and interferon (IFN)-γ have been reported elevated in psoriatic patients.…”
Get full text
Article -
252
Contribution of Genetic Factors to Sjögren’s Syndrome and Sjögren’s Syndrome Related Lymphomagenesis
Published 2015-01-01“…Moreover, genetic variations outside the MHC locus involving genes in type I interferon pathway, NF-κB signaling, B- and T-cell function and methylation processes have been shown to be associated with both SS and SS-related lymphoma development. …”
Get full text
Article -
253
Treatment of HIV-1 Infection with Combination Therapy: Antiretroviral Agents and Biological Response Modifiers
Published 1994-01-01“…Preliminary evaluations of the combination of zidovudine wilh interferon alpha (IFN-α) have demonstrated enhanced antiviral. antitumour and immunomodulatory activity. …”
Get full text
Article -
254
Vancomycin Hypersensitivity Diagnosed by Lymphocyte Blast Transformation
Published 2011-01-01“…Lymphocyte blast transformation (LBT), a method of detecting cellular immune response by measuring levels of interferon-γ (IFN-γ), was used to diagnose vancomycin hypersensitivity and guide antibiotic selection.…”
Get full text
Article -
255
Recurrent Respiratory Papillomatosis Causing Chronic Stridor and Delayed Speech in an 18-Month-Old Boy
Published 2006-01-01“…CO2 laser evaporation of papillomas and adjuvant drug therapy using lymphoblastoid interferon-alpha are the most common treatments. However, several other treatments have been tried, with varying success. …”
Get full text
Article -
256
Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
Published 2000-01-01“…Corresponding in vitro investigation has shown that T helper 1 (Th1) -mediated cytokine production of interferon-gamma is downregulated in the involved mucosa to a level consistent with that seen in uninflamed mucosa. …”
Get full text
Article -
257
Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
Published 2012-11-01“…New algorithms of antiviral therapy for patients infected by the 1-st virus genotype not treated earlier, and after treatment failure, implicate presence or absence of so-called «induction phase», the kernel of which is application of pegilated interferon-α and ribavirin combination at the beginning of treatment with subsequent addition of the third agent (the direct action antiviral agent). …”
Get full text
Article -
258
Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
Published 2009-02-01“…At CHC patients with the rapid virologic response (absence of viremia at the 4-th week) it is possible to limit duration of treatment by pegilated interferon and ribavirin in the case of the 1-st HCV genotype to 24 wks, in the case of the 2 and 3-rd genotypes to 12–16 wk. …”
Get full text
Article -
259
Role of Carbamazepine in the Symptomatic Treatment of Subacute Sclerosing Panencephalitis: A Case Report and Review of the Literature
Published 2013-01-01“…Combination immunomodulatory therapy with isoprinosine, ribavirin, and intra-Ommaya interferon alpha did not result in clinical improvement. …”
Get full text
Article -
260
Induction Versus Noninduction Antiviral Therapy for Chronic Hepatitis C Virus in Patients with Congenital Coagulation Disorders: A Canadian Multicentre Trial
Published 2007-01-01“…The present study compared induction therapy with interferon-alpha (IFN-α)-2b with standard IFN-α2b therapy. …”
Get full text
Article